Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
-
New triple-drug combo shows promise for advanced kidney cancer
Disease control OngoingThis study tests whether adding a supplement called Seleno-L Methionine to two standard drugs (axitinib and pembrolizumab) is safe and effective for people with advanced or spreading clear cell kidney cancer. About 55 participants will receive the combination therapy. The goal is…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a common bone drug help fight a rare cancer?
Disease control OngoingThis phase 1b trial is testing whether giving zoledronic acid, a drug usually used for bone thinning, before surgery can help people with chondrosarcoma, a rare bone cancer. Seventeen adults with any grade of the disease that can be surgically removed will receive the drug and th…
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC